670,758 Shares in Aehr Test Systems $AEHR Purchased by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. bought a new stake in Aehr Test Systems (NASDAQ:AEHRFree Report) during the second quarter, HoldingsChannel.com reports. The fund bought 670,758 shares of the semiconductor company’s stock, valued at approximately $64,433,000.

Several other institutional investors have also recently bought and sold shares of AEHR. BlackRock Inc. acquired a new position in Aehr Test Systems during the 2nd quarter worth approximately $255,476,000. Wellington Management Group LLP grew its stake in shares of Aehr Test Systems by 129.9% during the 4th quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company’s stock worth $16,771,000 after acquiring an additional 469,400 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Aehr Test Systems by 1,137.2% in the third quarter. Invesco Ltd. now owns 366,570 shares of the semiconductor company’s stock valued at $11,037,000 after purchasing an additional 336,940 shares during the last quarter. Next Century Growth Investors LLC raised its holdings in shares of Aehr Test Systems by 99.9% in the fourth quarter. Next Century Growth Investors LLC now owns 552,506 shares of the semiconductor company’s stock valued at $11,155,000 after purchasing an additional 276,160 shares during the last quarter. Finally, Halter Ferguson Financial Inc. raised its holdings in shares of Aehr Test Systems by 41.7% in the fourth quarter. Halter Ferguson Financial Inc. now owns 642,129 shares of the semiconductor company’s stock valued at $12,965,000 after purchasing an additional 189,117 shares during the last quarter. Institutional investors own 69.69% of the company’s stock.

Analyst Upgrades and Downgrades

AEHR has been the subject of several recent research reports. Weiss Ratings cut shares of Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Jefferies Financial Group started coverage on shares of Aehr Test Systems in a research note on Thursday, August 13th. They issued a “buy” rating and a $175.00 price target on the stock. Lake Street Capital restated a “buy” rating and set a $110.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Freedom Capital raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Finally, Craig Hallum restated a “buy” rating and set a $125.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $136.67.

Read Our Latest Stock Analysis on AEHR

Aehr Test Systems Price Performance

AEHR opened at $101.73 on Monday. Aehr Test Systems has a 12-month low of $17.33 and a 12-month high of $147.40. The business has a 50 day moving average of $94.63 and a 200-day moving average of $74.93. The stock has a market cap of $3.32 billion, a price-to-earnings ratio of -423.86 and a beta of 3.10.

Insiders Place Their Bets

In related news, Director Rhea J. Posedel sold 5,973 shares of the stock in a transaction on Friday, August 14th. The stock was sold at an average price of $140.00, for a total value of $836,220.00. Following the sale, the director owned 381,989 shares in the company, valued at approximately $53,478,460. This represents a 1.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Alberto Salamone sold 9,672 shares of the firm’s stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $127.72, for a total value of $1,235,307.84. Following the sale, the executive vice president directly owned 41,962 shares of the company’s stock, valued at $5,359,386.64. This represents a 18.73% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 109,475 shares of company stock worth $13,827,160 in the last quarter. Company insiders own 6.80% of the company’s stock.

Aehr Test Systems Profile

(Free Report)

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

Further Reading

Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHRFree Report).

Institutional Ownership by Quarter for Aehr Test Systems (NASDAQ:AEHR)

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.